KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Ratio (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Equity Ratio readings, the most recent being 0.46 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 8.01% to 0.46 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.46, a 8.01% decrease, with the full-year FY2025 number at 0.48, down 4.92% from a year prior.
  • Equity Ratio hit 0.46 in Q1 2026 for Thermo Fisher Scientific, down from 0.48 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.51 in Q4 2024 to a low of 0.44 in Q2 2022.
  • Median Equity Ratio over the past 5 years was 0.47 (2023), compared with a mean of 0.48.
  • Biggest five-year swings in Equity Ratio: fell 16.85% in 2022 and later increased 7.58% in 2024.
  • Thermo Fisher Scientific's Equity Ratio stood at 0.45 in 2022, then grew by 4.42% to 0.47 in 2023, then grew by 7.58% to 0.51 in 2024, then fell by 4.92% to 0.48 in 2025, then decreased by 5.29% to 0.46 in 2026.
  • The last three reported values for Equity Ratio were 0.46 (Q1 2026), 0.48 (Q4 2025), and 0.5 (Q3 2025) per Business Quant data.